ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis

NYSE:ELV • US0367521038

342.93 USD
-5.25 (-1.51%)
At close: Feb 20, 2026
342.93 USD
0 (0%)
After Hours: 2/20/2026, 4:10:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ELV. ELV was compared to 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ELV while its profitability can be described as average. ELV is not valued too expensively and it also shows a decent growth rate. Finally ELV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ELV was profitable.
  • In the past year ELV had a positive cash flow from operations.
  • Each year in the past 5 years ELV has been profitable.
  • In the past 5 years ELV always reported a positive cash flow from operatings.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • ELV's Return On Assets of 4.66% is fine compared to the rest of the industry. ELV outperforms 74.51% of its industry peers.
  • ELV has a Return On Equity of 12.90%. This is in the better half of the industry: ELV outperforms 78.43% of its industry peers.
  • ELV's Return On Invested Capital of 5.39% is in line compared to the rest of the industry. ELV outperforms 58.82% of its industry peers.
  • ELV had an Average Return On Invested Capital over the past 3 years of 6.61%. This is below the industry average of 8.98%.
Industry RankSector Rank
ROA 4.66%
ROE 12.9%
ROIC 5.39%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.61%
ROIC(5y)7.03%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ELV's Profit Margin of 2.84% is fine compared to the rest of the industry. ELV outperforms 65.69% of its industry peers.
  • ELV's Profit Margin has declined in the last couple of years.
  • ELV's Operating Margin of 4.07% is in line compared to the rest of the industry. ELV outperforms 59.80% of its industry peers.
  • In the last couple of years the Operating Margin of ELV has declined.
Industry RankSector Rank
OM 4.07%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELV is destroying value.
  • ELV has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ELV has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ELV has an improved debt to assets ratio.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • The Debt to FCF ratio of ELV is 10.10, which is on the high side as it means it would take ELV, 10.10 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ELV (10.10) is comparable to the rest of the industry.
  • ELV has a Debt/Equity ratio of 0.71. This is a neutral value indicating ELV is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ELV (0.71) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 10.1
Altman-Z N/A
ROIC/WACC0.66
WACC8.19%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ELV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.49%.
  • Measured over the past 5 years, ELV shows a small growth in Earnings Per Share. The EPS has been growing by 6.12% on average per year.
  • ELV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.62%.
  • Measured over the past years, ELV shows a quite strong growth in Revenue. The Revenue has been growing by 10.32% on average per year.
EPS 1Y (TTM)-8.49%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%-13.28%
Revenue 1Y (TTM)12.62%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%9.61%

3.2 Future

  • ELV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.55% yearly.
  • Based on estimates for the next years, ELV will show a small growth in Revenue. The Revenue will grow by 2.69% on average per year.
EPS Next Y-13.28%
EPS Next 2Y-1.35%
EPS Next 3Y4.53%
EPS Next 5Y8.55%
Revenue Next Year-2.33%
Revenue Next 2Y0.27%
Revenue Next 3Y1.79%
Revenue Next 5Y2.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.37 indicates a reasonable valuation of ELV.
  • ELV's Price/Earnings ratio is rather cheap when compared to the industry. ELV is cheaper than 87.25% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.09, ELV is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 13.11, ELV is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 83.33% of the companies listed in the same industry.
  • ELV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.98.
Industry RankSector Rank
PE 11.37
Fwd PE 13.11
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ELV is valued a bit cheaper than the industry average as 73.53% of the companies are valued more expensively.
  • ELV's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.85
EV/EBITDA 10.28
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.86
EPS Next 2Y-1.35%
EPS Next 3Y4.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • ELV has a Yearly Dividend Yield of 2.05%.
  • Compared to an average industry Dividend Yield of 0.48, ELV pays a better dividend. On top of this ELV pays more dividend than 92.16% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, ELV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.05%

5.2 History

  • On average, the dividend of ELV grows each year by 12.16%, which is quite nice.
  • ELV has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.16%
Div Incr Years13
Div Non Decr Years13
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • ELV pays out 27.00% of its income as dividend. This is a sustainable payout ratio.
  • ELV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27%
EPS Next 2Y-1.35%
EPS Next 3Y4.53%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ELEVANCE HEALTH INC

NYSE:ELV (2/20/2026, 4:10:03 PM)

After market: 342.93 0 (0%)

342.93

-5.25 (-1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-28
Earnings (Next)04-20
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change0%
Market Cap75.68B
Revenue(TTM)199.13B
Net Income(TTM)5.66B
Analysts75
Price Target401.08 (16.96%)
Short Float %1.63%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield 2.05%
Yearly Dividend6.8
Dividend Growth(5Y)12.16%
DP27%
Div Incr Years13
Div Non Decr Years13
Ex-Date03-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.74%
Min EPS beat(2)6.46%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)7.33%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)6
Avg EPS beat(8)1.93%
EPS beat(12)9
Avg EPS beat(12)1.87%
EPS beat(16)12
Avg EPS beat(16)2.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.45%
Revenue beat(4)3
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-2%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)6
Avg Revenue beat(12)0.63%
Revenue beat(16)9
Avg Revenue beat(16)0.61%
PT rev (1m)1.81%
PT rev (3m)1.83%
EPS NQ rev (1m)3.92%
EPS NQ rev (3m)-0.12%
EPS NY rev (1m)-4.19%
EPS NY rev (3m)-5.14%
Revenue NQ rev (1m)-4.45%
Revenue NQ rev (3m)-4.62%
Revenue NY rev (1m)-5.46%
Revenue NY rev (3m)-5.35%
Valuation
Industry RankSector Rank
PE 11.37
Fwd PE 13.11
P/S 0.38
P/FCF 23.85
P/OCF 17.64
P/B 1.72
P/tB 17.45
EV/EBITDA 10.28
EPS(TTM)30.17
EY8.8%
EPS(NY)26.16
Fwd EY7.63%
FCF(TTM)14.38
FCFY4.19%
OCF(TTM)19.44
OCFY5.67%
SpS902.24
BVpS198.83
TBVpS19.66
PEG (NY)N/A
PEG (5Y)1.86
Graham Number367.39
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 12.9%
ROCE 6.75%
ROIC 5.39%
ROICexc 5.85%
ROICexgc 10.18%
OM 4.07%
PM (TTM) 2.84%
GM N/A
FCFM 1.59%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.61%
ROIC(5y)7.03%
ROICexc(3y)7.13%
ROICexc(5y)7.56%
ROICexgc(3y)13.02%
ROICexgc(5y)14.04%
ROCE(3y)8.29%
ROCE(5y)8.81%
ROICexgc growth 3Y-11.47%
ROICexgc growth 5Y-9.01%
ROICexc growth 3Y-9.05%
ROICexc growth 5Y-6.9%
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 10.1
Debt/EBITDA 3.2
Cap/Depr 72.19%
Cap/Sales 0.56%
Interest Coverage 250
Cash Conversion 44.42%
Profit Quality 56.06%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.19%
ROIC/WACC0.66
Cap/Depr(3y)78.87%
Cap/Depr(5y)77.78%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.71%
Profit Quality(3y)81.36%
Profit Quality(5y)97.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.49%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%-13.28%
EPS Next Y-13.28%
EPS Next 2Y-1.35%
EPS Next 3Y4.53%
EPS Next 5Y8.55%
Revenue 1Y (TTM)12.62%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%9.61%
Revenue Next Year-2.33%
Revenue Next 2Y0.27%
Revenue Next 3Y1.79%
Revenue Next 5Y2.69%
EBIT growth 1Y-11.4%
EBIT growth 3Y-1.51%
EBIT growth 5Y1.02%
EBIT Next Year1.62%
EBIT Next 3Y13.19%
EBIT Next 5Y6.59%
FCF growth 1Y-29.25%
FCF growth 3Y-24.06%
FCF growth 5Y-19.97%
OCF growth 1Y-25.29%
OCF growth 3Y-20.06%
OCF growth 5Y-16.69%

ELEVANCE HEALTH INC / ELV FAQ

Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to ELV.


Can you provide the valuation status for ELEVANCE HEALTH INC?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.


What is the profitability of ELV stock?

ELEVANCE HEALTH INC (ELV) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ELEVANCE HEALTH INC (ELV) stock?

The Price/Earnings (PE) ratio for ELEVANCE HEALTH INC (ELV) is 11.37 and the Price/Book (PB) ratio is 1.72.


Can you provide the expected EPS growth for ELV stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (ELV) is expected to decline by -13.28% in the next year.